Related Experiment Video
Updated: Apr 14, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
[Neonatal screening of severe combined immunodeficiencies]
C Thomas1, S Mirallié2, C Pierres3
1Service d'hématologie et d'immunologie pédiatrique, hôpital Mère-Enfants, 7, quai Moncousu, 44000 Nantes, France.
Insights
Newborn screening for Severe Combined Immunodeficiencies (SCID) using TREC analysis is effective. Early detection through universal screening significantly improves survival rates and is cost-effective for infants.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Context:
- Severe Combined Immunodeficiencies (SCID) are inherited immune system disorders affecting T-cell development.
- Infants with SCID face life-threatening infections if not diagnosed and treated promptly.
- Newborn screening is crucial as SCID is asymptomatic at birth but fatal within the first year without intervention.
Purpose:
- To evaluate the clinical utility and cost-effectiveness of a nationwide newborn screening program for SCID in France.
- To demonstrate the benefits of universal SCID screening in early detection and improved outcomes.
- To assess the feasibility of using T-cell receptor excision circles (TRECs) for SCID screening.
Summary:
- A prospective nationwide study screened 200,000 French newborns for SCID over two years.
- The screening utilized the quantification of T-cell receptor excision circles (TRECs) in Guthrie samples.
- The study aimed to confirm SCID's suitability for population-based screening due to its treatability and impact on survival.
Impact:
- Early detection of SCID through universal screening significantly improves infant survival.
- Hematopoietic stem cell transplantation, when performed early, enhances immune reconstitution and quality of life.
- The study suggests that universal SCID screening is clinically beneficial and relatively cost-effective despite the disease's low incidence.
Abstract:
Severe combined immunodeficiencies (SCID) are a group of inherited diseases of the immune system characterized by profound abnormalities of T-cell development. Infants with SCID require prompt clinical intervention to prevent life-threatening infection and studies show significantly improved survival in babies diagnosed at birth based on previous family history. SCID follows the criteria for population-based newborn screening because it is asymptomatic at birth and fatal within the 1st year of life if there is no intervention, the confirmation of the disease is easy, there is a curative treatment, and it is known that early hematopoietic stem cell transplantation significantly improves survival, the quality of immune reconstitution, and quality of life. Quantification of T-cell receptor excision circles (TRECs) in DNA extracted from Guthrie samples is a sensitive and specific screening test for SCID. We conducted a nationwide prospective study of neonatal screening of SCID in a population of 200,000 French newborns over a period of 2 years. The objective was to study the clinical utility and the cost-effectiveness ratio, and to demonstrate that universal SCID screening could result in a substantial benefit to detect individuals, making screening relatively cost-effective in spite of the low incidence of the disease.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cytomegalovirus Disease

